Phase IIB Rheumatoid Arthritis Dose Ranging Study for BMS-945429 in Subjects Who Are Not Responding to Methotrexate

This study has been completed.
Information provided by (Responsible Party):
Alder Biopharmaceuticals, Inc. Identifier:
First received: June 13, 2011
Last updated: July 24, 2015
Last verified: July 2015
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: June 2015
  Primary Completion Date: September 2012 (Final data collection date for primary outcome measure)
  Certification or Request for Extension to Delay Results Received: July 24, 2015